March 2018 Issue
CE & Training
A factor Xa inhibitor for prophylaxis of venous thromboembolism (VTE) due to restricted mobility or other VTE risk factors during hospitalization.
New extended-release injection formulation for opioid use disorder.
A GLP-1 agonist for type 2 diabetes.